Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and ...

Oskar Hansson, a professor of neurology at Lund University, will hold the title of Vice President for Neurodegenerative Disease Early Phase Clinical and Imaging Development at the American ...

Nu tar redaktionen julledigt, men passar på att påminna om några artiklar från hösten som du kanske missade. Vi önskar alla ...

Enligt ett pressmeddelande avgår Hans Wigzell på egen begäran, och styrelsen inleder omedelbart arbetet för att hitta en ny ordförande. Någon orsak anges inte, men beskedet kommer bara en dryg vecka ...

American Merck & Co, known in Europe as MSD, has discontinued the development of vibostolimab and favezelimab, two experimental cancer drugs, after their failure in several trials, according to a ...

Ultimovacs is developing the cancer vaccine UV1, which aims to enhance and improve the effect of immunotherapy in various forms of cancer. Zelluna is developing immunotherapies against solid tumors.

– We look for pioneering companies. That's according to Thomas Eldered, chairman of the board of Flerie Invest, who was one of the speakers at Life Science Sweden's Pharma Outsourcing event last week.

Amerikanska Merck & Co, som i Europa är känt som MSD, har beslutat att avbryta utvecklingen av läkemedlen vibostolimab och favezelimab efter flera motgångar, enligt ett pressmeddelande. Dessa ...

The new factory, including a warehouse, will cover 40,000 square meters. Construction has already begun, and the facility is expected to be completed in 2027, according to a press release. – We are ...

The announcement came after a review that has been ongoing within the European Medicines Agency (EMA) since October last year, and means that its Committee for Medicinal Products for Human Use (CHMP) ...

”Ska vi få en så ljus framtid som möjligt där AI används på bästa sätt behövs både de som ser risker med den nya tekniken och de som ser sig som teknikoptimister”, skriver Samuel Lagercrantz i en ...

Approximately 60-70% of infectious diseases are viral, including COVID-19, influenza, MPXV, HIV, and Ebola. These viruses continue to affect human health and socio-economic development. Therefore, it ...